Scandion Oncology
Overcoming cancer drug resistance

Navbar

About us
Research & Development
Press releases
Investors & Media
Contact
- Career
- Business development

Skip to content

Edison Open House: Global Healthcare 2022

Watch the interview with President & CEO, Bo Rode Hansen released on January 26, 2022

Post navigation

Redeye Fight Cancer Seminar

Aktieinfo Investor Conference

Frontpage
Press releases
Edison Open House: Global Healthcare 2022

About us

About us
Executive Management
Board of Directors
Clinical Advisory Board

Research & Development

Research & Development
Pipeline
Clinical Development
Science

Investors & Media

Investors & Media
Share information
Financial Reports
Presentations
Media
Analyst Coverage
Prospectuses
Corporate governance
Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.